55 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and other liabilities (note 8)
Liability classified as held for sale (note 16)
Total Current Liabilities
Non-Current Liabilities
Other long-term Liabilities … term, revenues. There are no assurances, however, that the Company will be successful in obtaining the financing necessary for its long-term development
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
and long-term lease liabilities, as applicable.
Operating lease liabilities and their corresponding right-of-use assets are initially recorded based
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
Current Liabilities
Accounts payable
Accrued expenses and other liabilities
Total Current Liabilities
Non-Current Liabilities
Other long-term liabilities … term, revenues. There are no assurances, however, that the Company will be successful in obtaining the financing necessary for its long-term development
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
compensation to our officers and directors in order to further align their compensation with the long-term interests of our shareholders.
Proposed
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
studies and material consumption.
As of June 30, 2023, Enlivex had cash and cash equivalents, short term bank deposits and long term interest-bearing
6-K
EX-99.1
la34yhx
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
qd71j58hnqli4b3 rf0
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
ci8lw1 iskgoah
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.2
ozfswn45j8whf5mind9e
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
vqkxm4y4
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
cjnir
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
oa71j30
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
yesmkv8
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
34zcydix
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
n5nm5xzmo
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
htbrqrsc lowubn
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
mr8puhq16xzv3
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
ugo51oesshq4bu0i9s
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
p132ue2j
27 May 22
Condensed Consolidated Financial Statements
4:39pm